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Abstract
Here, we determined the potential of photochemotherapy, namely the application of photodynamic compounds
followed by exposure to a suitable source of UV-visible radiation against corneal pathogen, Acanthamoeba.
Organometallic macromolecule, tin porphyrin [Sn(IV)porphyrin] was synthesized and purity confirmed using nuclear
magnetic resonance spectroscopy. The Sn(IV)porphyrin was tested against a keratitis isolate of Acanthamoeba
castellanii belonging to the T4 genotype using growth and viability assays. The effects of Sn(IV)porphyrin on A.
castellanii binding to and cytopathogenicity of human corneal epithelial cells in vitro were tested. The
metalloporphyrin showed potent amoebistatic effects. The tin porphyrin inhibited amoebae binding to and
cytopathogenicity of corneal epithelial cells. By using derivatives of photodynamic compounds [Sn(IV)porphyrin-
antibody conjugates] for selective targeting of the parasite together with appropriate selection of light source will
determine the potential of photochemotherapy against Acanthamoeba keratitis.
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Introduction
Due to increasing resistance of infectious micro-
organisms to antimicrobial agents, it is becoming obvi-
ous to find alternative strategies for successful treatment
of these devastating infections. Among others, Acanth-
amoeba keratitis is a serious human disease with sight-
threatening consequences (Khan, 2009). Current treat-
ment is problematic and involves hourly topical applica-
tion of a cocktail of drugs including chlorhexidine,
polyhexamethylene biguanide, propamidine isethionate,
neomycin, and even then recurrence can occur (Ficker
et al., 1990; Perez-Santonja et al., 2003). This is of par-
ticular concern in the absence of available alternative
chemotherapeutic agents.
Photochemotherapy, namely the application of photo-
dynamic compounds followed by exposure to a suitable
source of UV-visible radiation, holds promise in future
antimicrobial therapy (Hamblin and Hasan, 2004; Huang
et al., 2010), particularly in eye infections due to ease of
visible light usage. Here, we determined the potential of
photodynamic compound, Sn(IV)porphyrin against a
eukaryotic corneal pathogen, Acanthamoeba. Sn(IV)
porphyrin is a synthetic metalloporphyrin that is a suit-
able tin porphyrin for catalytic and photocatalytic appli-
cation because of the presence of a single metal
oxidation state (Sardana and Kappas, 1987). Addition-
ally, many derivatives can be formed with a variety of
anions, which is important in the synthesis of an effi-
cient photosensitizer. The formation of these derivatives
is possible owing to the Sn(IV)centre, which is usually
six-coordinate with two trans-diaxial ligands.
Methods
Synthesis of Sn(IV)porphyrin
Sn(IV)porphyrin was synthesized as follows: 250 mg of
5, 10, 15, 20-meso tetraphenyl porphyrine (TPP) and
200 mg stannous chloride (SnCl2.2H2O) were stirred
and refluxed in 25 mL of pyridine in condensor at 115°C
for 24 h. Approximately, 150 mL H2O was added and
the solution was allowed to cool at room temperature.
The crystals of Sn(IV)porphyrin were collected by vac-
uum filtration, washed with water and dried by vacuum
suction yielding 250 mg of product, which showed max-
imum solubility in DMSO. The stock solution of Sn(IV)
porphyrin was maintained in 10 mM concentration and
stored in −4°C.
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Growth and viability assays
The effects of Sn(IV)porphyrin on Acanthamoeba viabil-
ity and growth were determined. A clinical isolate of A.
castellanii from a keratitis patient (ATCC 50492) was
grown in PYG and incubated with Sn(IV)porphyrin (10,
50, 100 μM) in 24-well plates (2.5 x 105 amoebae/mL/well)
for 24 h under visible light. Amoebicidal and amoebistatic
effects were determined using haemocytometer counting
(Siddiqui et al., 2012) and Trypan blue exclusion testing
(Thorson et al., 1995). For controls, amoebae were
incubated with solvent alone (i.e., DMSO). Normal
growth rates were determined using growth medium
alone and considered as 100%. The results were presented
as relative percent of A. castellanii incubated in PYG.
Experiments were performed in duplicate and repeated at
least three times.
Adhesion assays
Adhesion assays were performed to determine the
effects of Sn(IV)porphyrin on A. castellanii binding to
human corneal epithelial cells (HCEC). HCEC were
grown to confluency in 24-well plates in RPMI-1640
containing 10% foetal calf serum and 2 mM glutamine
(Sissons et al., 2005; Araki-Sasaki et al., 2000). A. castellanii
(106 amoebae/well) were pre-incubated with various
concentrations of Sn(IV)porphyrin or solvent alone
for 45 min under visible light and then added to cell
monolayers for 1 h and percentage binding determined as
follows: 100 – [no. of unbound amoebae/total number of
amoebae x 100] =% bound amoebae.
Cytopathogenicity assays
Cytopathogenicity assays were performed to determine
effects of Sn(IV)porphyrin on A. castellanii-mediated
HCEC death. Amoebae were pre-incubated with Sn(IV)
porphyrin or solvent alone as per adhesion assays.
Amoebae were collected by centrifugation and resus-
pended in RPMI 1640 without Sn(IV)porphyrin and
added to cell monolayers. Plates were incubated at 37°C
in a 5% CO2 incubator for 24 h. Cytopathogenicity was
determined by measuring lactate dehydrogenase release
as follows: (sample value – control value/total LDH re-
lease – control value x 100 =% cytopathogenicity) (Sissons
et al., 2005). Control values were obtained from HCEC
incubated in RPMI alone. Total LDH release was deter-
mined from HCEC treated with 5% Triton X-100 for
30 min at 37°C.
Results
NMR spectroscopy confirmed the purity of Sn(IV)
porphyrin
To confirm purity of Sn(IV)porphyrin, octahedral Sn(IV)
complex, TPPSnCl2 was dissolved in C6D6 solvent and
studied for chemical shifts and couplings constants be-
tween different position of hydrogen atoms. The calcu-
lated meso proton chemical shift for TPP complex was
9.02 ppm and average coupling constant J(SnH) was
found to be 14.9 Hz. The results calculated from NMR
spectrum were tallied with experimental study of where
their chemical shift was 9.18 (our experiment revealed 9.02)
and average coupling constant was 15.2 Hz (our
experiment revealed 14.7 Hz), indicating similarities in the
structure of the molecule and the number of neighboring
NMR active nuclei within the molecule. Overall, NMR
spectrum revealed chemical shift (σ) at meso proton signal
(β pyrrole) to be 9.02 ppm. Average of 119 Sn-1H and
117Sn-1H coupling constants, i.e., J (SnH) to meso proton
(β pyrrole) was 14.7 Hz.
Sn(IV)porphyrin inhibited A. castellanii growth but no
effect on its viability
At micromolar concentrations, Sn(IV)porphyrin exhibited
significant amoebistatic effects compared with amoebae
incubated with solvent alone (P < 0.05, as standard level of
significance, when Sn(IV)porphyrin-treated samples were
compared with solvent-treated samples using T-test,
paired, one-tail distribution) (Table 1). Both 10 μM and
50 μM concentrations of Sn(IV)porphyrin inhibited amoe-
bae growth by 51% ± 6.3 and 73% ± 4.4 respectively, while
solvent alone inhibited A castellanii growth by 12% ± 2.1
(Table 1). In contrast, Sn(IV)porphyrin had no effect on
the viability of A. castellanii (Table 1).
Sn(IV)porphyrin inhibited A castellanii adhesion to and
cytopathogenicity of human corneal epithelial cells
The results revealed that Sn(IV)porphyrin significantly
reduced amoebae binding to HCEC monolayers, com-
pared with amoebae incubated with solvent (P < 0.05 as
Table 1 Effect of Sn(IV)porphyrin on biological properties of Acanthamoeba castellanii
% Growth
inhibition
% Viability
inhibition
% Adhesion
inhibition
% Cytopathogenicity
inhibition
Acanthamoeba + solvent 12%±2.1 2.1%±1.1 6.8%±0.4 11.7%±0.8
Acanthamoeba + Sn(IV)porphyrin (10μM) 51%±6.3 4.5%±0.3 12.7%±2.3 15.4%±2.2
Acanthamoeba + Sn(IV)porphyrin (50μM) 73%±4.4 7.3%±2.2 44%±4.1 58.8%±6.2
Acanthamoeba + Sn(IV)porphyrin
(100μM)
98.2%±5.3 12.7%±1.3 67%±3.2 72.3%±5.2
Data are presented as the mean ± standard error of three independent experiments performed in duplicate.
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standard level of significance using T-test, paired, one-
tail distribution) (Table 1). At 50 μM and 100 μM con-
centrations, Sn(IV)porphyrin inhibited amoebae binding
to HCEC monolayers by 44% ± 4.1 and 67% ± 3.2 re-
spectively. A. castellanii incubated with solvent had no
effect on adhesion of amoebae to HCEC. Cytopathogeni-
city assays were performed to determine the effect of Sn
(IV)porphyrin on A. castellanii-mediated HCEC death.
A. castellanii alone produced 85% ± 3.8 HCEC death
within 24 h. With solvent, A. castellanii–mediated
HCEC death was inhibited by 11.7% ± 0.8. In the pres-
ence of 50 μM Sn(IV)porphyrin, A. castellanii-mediated
HCEC cytopathogenicity was significantly inhibited
58.8% ± 6.2 (P < 0.05 when Sn(IV)porphyrin-treated
samples were compared with solvent-treated samples
using T-test, paired, one tail distribution), which was fur-
ther reduced to 72.3% ± 5.2 at 100 μM of Sn(IV)porphy-
rin respectively.
Discussion
For the first time, these studies indicate that organometallic
macromolecule, tin porphyrin [Sn(IV)porphyrin] exhibit
potent amoebistatic effects suggesting that photoche-
motherapy holds promise in future antimicrobial therapy,
particularly in eye infections due to ease of visible light
usage. The use of visible light in our findings is particu-
larly significant as the present mode of eye inspection is
visible light. The basis of this technology is that visible
light (or light of appropriate wavelength) activates photo-
sensitising compound, resulting in production of singlet
oxygen and other reactive oxygen species (ROS) to induce
cell death in the target pathogen/tissue. If photosensitising
compounds can be specifically delivered to the pathogen,
there will be several advantages over the present treatment
of Acanthamoeba keratitis, which is laborious and involves
hourly topical application of mixture of drugs including
chlorhexidine, polyhexamethylene biguanide (PHMB),
neomycin and propamidine isethionate that can last up to
a year with associated side effects and even then recur-
rence can occur (Khan, 2009). In the present study, the
synthetic Sn(IV)porphyrin macromolecule incorporated
a closed shell Sn(IV) into the porphyrin molecule affecting
the ground state optical spectrum and fluorescence
spectrum. This photophysical or photosensitizing property
of the diamagnetic complex i.e., Sn(IV)porphyrin shows an
increased triplet state lifetime important for photoactive
damage (Land et al., 1988).
Targeted treatment of eukaryotic pathogen remains a
major problem in our efforts to counter infectious dis-
eases. As opposed to bacterial pathogens with unique tar-
gets, the molecular and functional similarities in
eukaryotic pathogens to human cells make it particularly
challenging to find novel targets for therapeutic interven-
tions. The synthesis of derivatives of these photodynamic
compounds in order to improve their selective attachment
to the parasite is a complete new approach to this infec-
tion. To this end, studies have shown the presence of an
adhesin, mannose-binding protein (MBP) on the surface
membranes of Acanthamoeba that is critical in its patho-
genesis (Alsam et al., 2003; Garate et al., 2004). For robust
and targeted killing, future studies will synthesize photo-
sensitizer-alpha-D-mannose conjugates of varying charges
as well as photosensitizer-MBP antibody conjugates. This
together with appropriate selection of light source (lasers)
to emit monochromatic light in the visible spectrum in a
given direction targeting and fully activating the photosen-
sitizer compound will determine the potential of photo-
chemotherapy to counter this devastating infection. In
addition, these studies will provide a model and stimulate
ongoing research in targeting other pathogens, which
cause serious eye infections.
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